Improved Survival with Bevacizumab in Advanced Cervical Cancer

Por Tewari, Krishnansu S., Sill, Michael W., Long, Harry J., Penson, Richard T., Huang, Helen, Ramondetta, Lois M., Landrum, Lisa M., Oaknin, Ana, Reid, Thomas J., Leitao, Mario M., Michael, Helen E., Monk, Bradley J.
Publicado em 2014

Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Por Tewari, Krishnansu S., Sill, Michael W., Monk, Bradley J., Penson, Richard T., Long, Harry J., Poveda, Andrés, Landrum, Lisa M., Leitao, Mario M., Brown, Jubilee, Reid, Thomas J.A., Michael, Helen E., Moore, David H.
Publicado no Clin Cancer Res (2015)

Patient Reported Outcomes in a Practice Changing Randomized Trial of Bevacizumab in the Treatment of Advanced Cervical Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Por Penson, Richard T., Huang, Helen Q., Wenzel, Lari B., Monk, Bradley J., Stockman, Sharon, Long, Harry J., Ramondetta, Lois M., Landrum, Lisa M., Oaknin, Ana, Reid, Thomas J.A., Leitao, Mario M., Method, Michael, Michael, Helen, Tewari, Krishnansu S.
Publicado no Lancet Oncol (2015)

Imagine a world without cancer

Por Brücher, Björn LDM, Lyman, Gary, van Hillegersberg, Richard, Pollock, Raphael E, Lordick, Florian, Yang, Han-Kwang, Ushijima, Toshikazu, Yeoh, Khay-Guan, Skricka, Tomas, Polkowski, Wojciech, Wallner, Grzegorz, Verwaal, Vic, Garofalo, Alfredo, D’Ugo, Domenico, Roviello, Franco, Steinau, Hans-Ulrich, Wallace, Timothy J, Daumer, Martin, Maihle, Nitah, Reid, Thomas J, Ducreux, Michel, Kitagawa, Yuko, Knuth, Alexander, Zilberstein, Bruno, Steele, Scott R, Jamall, Ijaz S
Publicado em 2014